Patents by Inventor Patrick Soon-Shiong
Patrick Soon-Shiong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250147944Abstract: Techniques including receiving a test digital token representing a game object and storing the test digital token. The techniques further include generating a set of token distinguishing features. The techniques further include obtaining a token result set based on the set of token distinguishing features. The techniques further including deriving at least one token similarity score based on the token result set and the set of token distinguishing features. The techniques further include updating the test digital token representing the game object based on satisfaction of similarity criteria according to the at least one token similarity score. The techniques further include determining a smart contract interface to invoke from a plurality of smart contract interfaces. The techniques further including invoking the smart contract interface based on the at least one token similarity score or the satisfaction of the similarity criteria.Type: ApplicationFiled: January 8, 2025Publication date: May 8, 2025Inventors: Patrick Soon-Shiong, John Wiacek, Nicholas J. Witchey, Jake Fyfe
-
Publication number: 20250144143Abstract: Compositions and methods are described for a treatment of enduring viral infection in general, and long COVID in particular. The composition comprises T cells, antigen presenting cells (APC), and optionally NK cells derived from the whole blood of a patient. The APC are genetically engineered to comprise nucleic acids encoding antigenic peptide sequences for MHC-complexed cell surface expression, wherein further exposure to an IL-15 agonist and patient T cells yields activation and expansion of virally-educated T cells for re-administration to the patient, whereby cells harboring the virus are targeted for T-cell mediated cytotoxicity.Type: ApplicationFiled: November 6, 2024Publication date: May 8, 2025Applicant: ImmunityBio, Inc.Inventor: Patrick Soon-Shiong
-
Publication number: 20250151455Abstract: Apparatus, methods and systems of wireless power distribution are disclosed. Embodiments involve the redirection of collimated energy to a converter, which stores or converts the energy into a more suitable form of energy for at least one specific point-of-use that is coupled to the converter.Type: ApplicationFiled: January 13, 2025Publication date: May 8, 2025Applicant: Nant Holdings IP, LLCInventor: Patrick Soon-Shiong
-
Patent number: 12293269Abstract: A method includes accessing a structured content item from a first database and event data from a second database, the event data including sets of event attributes in a multi-dimensional namespace and associated with a respective point in time; determining a relevancy profile characterizing a metric of relevancy of the structured content item over a respective time interval, the metric of relevancy including a distance in the multi-dimensional namespace between attributes associated with the structured content and the sets of event attributes; generating, using the relevancy profile, second digital content including a subset of the structured content item; and providing the second digital content for rendering on a device. Related apparatus, systems, techniques and articles are also described.Type: GrantFiled: June 24, 2024Date of Patent: May 6, 2025Assignee: Nant Holdings IP, LLCInventor: Patrick Soon-Shiong
-
Patent number: 12290558Abstract: Disclosed herein are methods for inducing immunity against a virus such as a coronavirus in the mucosal tissue of a patient, include administering a vaccine composition to the patient by oral administration (e.g., nasal injection, nasal inhalation, oral inhalation, and/or oral ingestion). Also disclosed are compositions for assaying the presence of anti-viral antibodies induced by the administered vaccine or the presence of viral proteins in a saliva sample include a stabilizing solution and may also include the use of aragonite particle beads. Compositions and methods are presented for prevention and/or treatment of a coronavirus disease wherein the composition comprises a recombinant entity. The recombinant entity is bivalent, comprising a nucleic acid encoding a coronavirus 2 nucleocapsid protein CoV2 nucleocapsid protein fused to an endosomal targeting sequence, and a nucleic acid encoding a CoV2 spike protein sequence optimized for cell surface expression.Type: GrantFiled: October 17, 2023Date of Patent: May 6, 2025Assignee: ImmunityBio, Inc.Inventors: Patrick Soon-Shiong, Peter Sieling, Kayvan Niazi, Shahrooz Rabizadeh, Lise Geissert, Annie Shin, Adrian Rice, Elizabeth Gabitzsch, Jeffrey Safrit, Leonard Sender
-
Publication number: 20250131055Abstract: A method of automated database element processing includes training a wide machine learning model with historical feature vector inputs to generate a wide ranked element output. The method includes training a deep machine learning model with the historical feature vector inputs to generate a deep ranked element output. The method includes generating a set of inputs specific to an individual entity, obtaining a set of current article database elements, and creating a feature vector input according to the set of inputs and the set of current article database elements. The method includes processing the feature vector input with the wide machine learning model to generate a wide ranked element list, processing the feature vector input with the deep machine learning model to generate a deep ranked element list, and merging database elements of the wide and deep ranked element lists to generate a ranked element recommendation output.Type: ApplicationFiled: December 19, 2024Publication date: April 24, 2025Inventors: Bing SONG, Jeffrey Michael BALBIEN, Hao LU, Phillip YANG, Patrick SOON-SHIONG
-
Publication number: 20250125009Abstract: Computer-based systems and methods are presented in which digital data from a subject are used to provide an initial diagnosis, and in which a polymerase chain reaction (PCR)-based assay is performed at the point-of-care to confirm and refine the initial diagnosis. Advantageously, the polymerase chain reaction (PCR)-based assay is configured as a hand-held portable device and uses a plurality of nucleic acid primers that are chosen as a function of the initial diagnosis. The primers are further chosen to allow for refinement of the initial diagnosis to enable generation of a treatment plan and assist in appropriate treatment at the point of care or use.Type: ApplicationFiled: October 17, 2024Publication date: April 17, 2025Applicant: Nant Holdings IP, LLCInventor: Patrick Soon-Shiong
-
Patent number: 12274748Abstract: An immunotherapeutic composition is contemplated that comprises subject-derived peripheral blood mononuclear cells (PBMC) and at least one recombinant adenovirus subtype 5 (Ad5) comprising a deletion in an E1 gene region, a deletion in an E2b gene region, and a nucleic acid sequence encoding a peptide antigen, wherein the PBMC are exposed ex-vivo to the at least one Ad5 vector. Advantageously, the same PBMC composition may also be used to prepare modified NK cells, and especially modified NK include CIML NK cells, CENK cells and mCENK cells.Type: GrantFiled: April 29, 2024Date of Patent: April 15, 2025Assignee: ImmunityBio, Inc.Inventors: Patrick Soon-Shiong, Elizabeth Gabitzsch, Philip T. Liu
-
Publication number: 20250118756Abstract: A cathode electrode assembly is disclosed, the cathode electrode assembly comprising an active material, a current collector, a conductive additive substance, and a polynorbornene-based (PNB) polymer binder configured to bind the active material and the conductive additive substance and maintain electrical contact between the active material and the conductive additive substance with the current collector. An alternative cathode electrode assembly comprising active material, a current collector, a conductive additive substance, a PNB polymer binder, and at least one polyacrylic acid (PAA) side chain configured to interface with the PNB polymer binder is also disclosed. A functional group is further disclosed, the functional group being configured to interface with a binder in a cathode electrode assembly of an electric battery system, the functional group comprising at least one PAA side chain.Type: ApplicationFiled: October 9, 2024Publication date: April 10, 2025Inventors: Fabio ALBANO, Nicolas BEDNAR, Taylor JURAN, Patrick SOON-SHIONG
-
Publication number: 20250115870Abstract: Cord blood or peripheral blood NK cells are prepared from whole blood mononuclear cells without the need to isolate CD34+ hematopoietic stem cells or NK cells, and without the need for a feeder layer. Advantageously, the methods presented herein use an enrichment process that uses antiCD16 agonist antibodies, antiCD3 antibodies, and N-803. Moreover, contemplated processes are suitable for adaptation into a fully automated production process (GMP in a box).Type: ApplicationFiled: December 18, 2024Publication date: April 10, 2025Applicant: ImmunityBio, Inc.Inventors: Rohit Duggal, Ranjeet Sinha, Wenzhao Li, Jason Isaacson, Karl Marquez, Patrick Soon-Shiong
-
Publication number: 20250117674Abstract: A reasoning engine is disclosed. Contemplated reasoning engines acquire data relating to one or more aspects of various environments. Inference engines within the reasoning engines review the acquire data, historical or current, to generate one or more hypotheses about how the aspects of the environments might be correlated, if at all. The reasoning engine can attempt to validate the hypotheses through controlling acquisition of the environment data.Type: ApplicationFiled: December 17, 2024Publication date: April 10, 2025Applicant: Nant Holdings IP, LLCInventor: Patrick Soon-Shiong
-
Patent number: 12268958Abstract: One exemplary aspect relates to normalizing latency in a networking environment to reduce the chances of creating an unfair advantage. While an exemplary aspect will be discussed in relation to a gaming environment, it is to be appreciated that the techniques disclosed herein can be applied to other environments where latency normalization or the ability to maintain latency between various endpoints is desired. For example, other environments include eSporting, on-line betting, fantasy esports, streaming services, etc. Some more specific examples include World of Warcraft®, Overwatch®, H1Z1®, PUBG®, Fortnite®, Realm Royale®, Planet Side 2®, real-time strategy games, slot machines, electronic poker tournaments, etc.Type: GrantFiled: February 27, 2024Date of Patent: April 8, 2025Assignee: Nant Holdings IP, LLCInventors: Patrick Soon-Shiong, John Wiacek, Nicholas J. Witchey
-
Patent number: 12272439Abstract: An autonomous tracking system receives a request to administer a patient-specific therapeutic comprising a scanned identifier associated with a labeled dual chamber device (DCD) including a first chamber having one or more lyophilized components, a second chamber having a reconstitution buffer, and a locking mechanism for controlling access to the DCD chambers. A tracking engine queries an administration database based on the scanned identifier to find a notarized ledger associated with the DCD and retrieves a blockchain entry comprising a first distributed ledger transaction identifying the one or more lyophilized components and a digital token associated with an owner of the labeled DCD. After the owner is authenticated, a second distributed transaction is created identifying the one or more lyophilized components as being authorized for administration to the patient. In response, autonomous access to the one or more lyophilized components unlocks the locking mechanism to administer the medication.Type: GrantFiled: May 6, 2024Date of Patent: April 8, 2025Assignee: ImmunityBio, Inc.Inventors: Patrick Soon-Shiong, Nicholas J. Witchey
-
Publication number: 20250109839Abstract: A wall module of a modular LED wall includes an array of LED panels and a truck for supporting the array of LED panels and providing mobility thereto relative to a stage surface. The truck may include a support assembly including a first support base fixed to the array of LED panels, a second support base engageable with the first, and a plurality of ball bearings arranged between the first and second support bases to allow relative movement of the first and second support bases in a plane parallel to the stage surface, a plurality of omnidirectional wheels arranged to enable omnidirectional movement of the second support base along the stage surface, and one or more actuators operable to adjust a height of the support assembly at a plurality of positions on the support assembly to enable leveling of the support assembly relative to the stage surface.Type: ApplicationFiled: October 2, 2024Publication date: April 3, 2025Applicant: NantStudios, LLCInventors: Gary Robert Marshall, Keaton Arthur Heinrichs, Christopher Paul Williams, Patrick Soon-Shiong
-
Publication number: 20250109409Abstract: Viral transfection and expression of recombinant viral payload in a transfected cell is enhanced by co-expression of a means of interfering with the expression of Retinoic Acid-Inducible Gene I (RIG-1). In some embodiments, the co-expression is driven from a tissue specific promoter.Type: ApplicationFiled: September 3, 2024Publication date: April 3, 2025Applicant: ImmunityBio, Inc.Inventor: Patrick Soon-Shiong
-
Patent number: 12267614Abstract: A distributed studio management system includes a computing system having a computer readable memory and a processor. The computing system is associated with a first production facility that is remote to a second production facility. The processor is configured to perform the operations of receiving a set of device commands having commands targeting first and second devices in the first production facility and where the set of device commands are related to the second production facility, enqueuing a first command from the device commands into a first command queue assigned to the first device and a second command from the device commands into a second command queue assigned to the second device according to each device command's synchronized execution times, and causing the first and second devices to execute commands from their respective command queues relative to each other according to the commands' respective synchronized execution times.Type: GrantFiled: November 26, 2024Date of Patent: April 1, 2025Assignees: NantStudios, LLC, Nant Holdings IP, LLCInventors: Patrick Soon-Shiong, Gary Marshall, Keaton Heinrichs, John Wiacek, Nicholas James Witchey
-
Patent number: 12263189Abstract: Compositions and methods are presented that include exosomes from stem cells and/or tumor cells that were previously exposed to an inflammatory stimulus. Advantageously, such exosomes exhibit anti-inflammatory and analgesic effect when administered to an individual. Therefore, a preferred use of such exosomes will reduce the need for opioid analgesics, and reduce pain and inflammation.Type: GrantFiled: October 17, 2019Date of Patent: April 1, 2025Assignee: NantBio, Inc.Inventors: Patrick Soon-Shiong, Francesco Curcio, Kayvan Niazi
-
Patent number: 12260940Abstract: Healthcare object (HCO) discriminator systems and methods are presented. Systems can obtain a digital representation of a scene via a sensor interface. An HCO discriminator platform analyzes the digital representation to discriminate objects within the scene as being associated with a type of HCO or as being unrelated to a type of HCO. Once the HCO recognition platform determines that a type of HCO is relevant, it instantiates an actual HCO. The HCO can be routed to one or more destinations based on routing rules generated from a template or based on the manner in which the objects in the scene were discriminated.Type: GrantFiled: August 30, 2024Date of Patent: March 25, 2025Assignee: Nant Holdings IP, LLCInventors: Patrick Soon-Shiong, John Zachary Sanborn, Stephen Charles Benz, Charles Joseph Vaske
-
Patent number: 12257528Abstract: Methods and systems for separating a first metal from a metal-containing feed stream are provided. The method can include applying solar energy, for example, by focusing one or more mirrors in one or more heliostats, to heat a metal-containing feed stream in a heating zone to a first temperature to produce a first vapor including the first metal. The first vapor can be condensed in a condensation zone to produce a first liquid including the first metal, and the first liquid can be collected. The system can include a separation unit include a heating zone in fluid communication with a condensation zone and a means for applying solar energy to heat a metal-containing feed stream disposed in the heating zone.Type: GrantFiled: September 22, 2023Date of Patent: March 25, 2025Assignee: Nant Holdings IP, LLCInventor: Patrick Soon-Shiong
-
Publication number: 20250095303Abstract: Interference-based augmented reality hosting platforms are presented. Hosting platforms can include networking nodes capable of analyzing a digital representation of scene to derive interference among elements of the scene. The hosting platform utilizes the interference to adjust the presence of augmented reality objects within an augmented reality experience. Elements of a scene can constructively interfere, enhancing presence of augmented reality objects; or destructively interfere, suppressing presence of augmented reality objects.Type: ApplicationFiled: November 20, 2024Publication date: March 20, 2025Applicant: Nant Holdings IP, LLCInventor: Patrick Soon-Shiong